Could iBio (IBIO) Be an Underrated Obesity Stock?
Yahoo Finance · Jun 12, 2026 · iBio, Inc. Common Stock (IBIO)
With 16 hedge funds having stakes in the stock, iBio, Inc. (NASDAQ:IBIO) is among the 10 Under-the-Radar AI Stocks to Buy in 2026. On June 8, Raymond James initiated coverage of iBio, Inc. (NASDAQ:IBIO) with an Outperform rating and a $5 price target, highlighting the company’s emerging obesity-focused pipeline and attractive risk-reward profile. The firm pointed to […]
Not investment advice. Cached headline, not a full reprint.